Cargando…
Small Molecules Targeting SARS-CoV-2 Spike Glycoprotein Receptor-Binding Domain
[Image: see text] The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the coronavirus disease 2019 (COVID-19) pandemic. Several variants of SARS-CoV-2 have emerged worldwide. These variants show different transmissibility infectivity due to mutations in the viral spike (S) gl...
Autores principales: | Rodríguez, Yoel, Cardoze, Scarlet Martínez, Obineche, Onyinyechi W., Melo, Claudia, Persaud, Ashanna, Fernández Romero, José A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380817/ https://www.ncbi.nlm.nih.gov/pubmed/35991504 http://dx.doi.org/10.1021/acsomega.2c00844 |
Ejemplares similares
-
Crystallization and Structural Determination of the Receptor-Binding Domain of MERS-CoV Spike Glycoprotein
por: Zhou, Haixia, et al.
Publicado: (2019) -
Site-specific characterization of SARS-CoV-2 spike glycoprotein receptor-binding domain
por: Antonopoulos, Aristotelis, et al.
Publicado: (2020) -
A Cryptic Site of Vulnerability on the Receptor Binding Domain of the SARS-CoV-2 Spike Glycoprotein
por: Joyce, M. Gordon, et al.
Publicado: (2020) -
Screening, simulation, and optimization design of small molecule inhibitors of the SARS-CoV-2 spike glycoprotein
por: Sun, Chuancai, et al.
Publicado: (2021) -
Heme binding to the SARS-CoV-2 spike glycoprotein
por: Freeman, Samuel L., et al.
Publicado: (2023)